$0.22
-0.01 (-4.46%)
Open$0.24
Previous Close$0.23
Day High$0.24
Day Low$0.22
52W High$3.39
52W Low$0.16
Volume—
Avg Volume4.39M
Market Cap27.54M
P/E Ratio—
EPS$-2.71
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+15,510.4% upside
Current
$0.22
$0.22
Target
$34.78
$34.78
$27.07
$34.78 avg
$51.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.02M | 6.51M | 5.83M |
| Net Income | -221,766,211 | -258,971,830 | -1,267,217 |
| Profit Margin | -4,416.2% | -4,195.4% | -21.7% |
| EBITDA | -225,672,461 | -278,174,176 | -1,820,131 |
| Free Cash Flow | — | — | -1,133,887 |
| Rev Growth | -22.9% | -22.9% | +8.5% |
| Debt/Equity | 1.25 | 1.25 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |